Persistent facial erythema is a redness of the facial skin and mostly noticeable in individuals with fair skin. The facial redness occurs due to dilation of cutaneous blood vessel and increased blood flow to the skin. Persistent facial erythema often goes undiagnosed among dark-skinned individuals. Facial erythema are caused due to several factors, including primary skin diseases such as rosacea and perioral dermatitis, and systemic illnesses. Facial erythema is characterized by burning skin, itching, dry skin, flushing, visible blood vessels, and pain. Rosacea affects millions of people worldwide and is a common chronic facial skin disease with female predominance, mostly those with fair skin. This skin disease typically affects the convexities of the central face. Erythematotelangiectatic rosacea, papulopustular rosacea, phymatous rosacea, and ocular rosacea are the four types of this skin disease. Each type of rosacea has different characteristics and the treatment depends on the severity of the lesion. According to AZoNetwork, a leading health care, life science online publisher in the U.K., the prevalence rate of rosacea is 1.65 per 1,000 person every year.
Factors such as large patient population, new product launch, increase in smoking, growth in consumption of alcohol, large pipeline drugs, and climatic change are projected to drive the global persistent facial erythema treatment market. According to the United Nations Population Fund (UNFPA), the human population worldwide is growing at a rate of 1.1%. Technological advancement and rapid rise in population are other factors which are expected to fuel the growth of the global market during the forecast period. However, generic competition and stringent regulations for product approvals are hindrances which are anticipated to restrict the market growth.
The global persistent facial erythema treatment market has been segmented by drug type, disease type, distribution channel, and geography. In terms of drug type, the market is classified into emollients, antihistamines, antifungal, antibiotics, corticosteroids, and calcineurin inhibitors. In terms of disease type, the market is classified into seborrhea, eczema, rosacea, acne, lupus, and tinea. In terms of distribution channel, the market is classified into hospitals pharmacies, retail pharmacies, and online pharmacies
In terms of geography, the market is distributed over North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Geographically, North America dominates the market owing to early treatment adoption, lifestyle changes, and new product innovation. These factors are projected to drive the market growth. A significant proportion of the U.S. population has symptoms of eczema. According to the National Eczema Association in the U.S., 31.6 million people are living with eczema and prevalence rate of childhood eczema is 10.7%. Europe is the second leading market for persistent facial erythema treatment market due to large research and development activities and increase in consumption of alcohol. In the next few years, the market in Asia Pacific is expected to grow at a higher rate due to larger target patient pool, changing lifestyle, rapid population growth, adoption of western lifestyle, and increase in research and development. The Latin America and Middle East & Africa markets are estimated to create a large opportunity for persistent facial erythema treatment due to climatic change, increase in importance of skin care, rise in consumption of alcohol which causes skin diseases, and growth in investment of key manufacturers. According to the Institute of Alcohol Studies, the worldwide average consumption of pure alcohol per adult is of 6.2 liter/year. In Brazil, the average is 8.7 liter/year.
The major players operating in this market include Astellas Pharma Inc., Sanofi S.A., Valeant Pharmaceuticals International, Inc., Novartis International AG, Pfizer Inc., Meda Pharmaceuticals, Regeneron Pharmaceuticals Inc., Galderma S.A., and Anacor Pharmaceuticals Inc.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.